Introduction: Identification of human papillomavirus (HPV) as the etiologic factor of cervical,
anogenital, and a subset of head and neck cancers has stimulated the development of …

Human papillomavirus (HPV) infections are a leading cause of virus-associated cancers of
the anogenital, oropharyneal and cutaneous epithelium. The most prevalent of these is …

… molccular biology of human papillomavirus (HPV) infection. Papillomaviruses consist of a 55
… Over 70 types of human papillomaviruses have been described. Over one-third of these are …

… that use virus-like particles as a vaccine antigen. This review discusses the current status
of HPVs vaccines on the global market, clinical trials, and the future of HPVs vaccine …

… However, strong arguments emerged for extending vaccination to adolescent boys over the
… effects following the introduction of human papillomavirus vaccination programmes: Updated …

… In 2007, five Emerging Infections Program (EIP) sites were funded to determine the … system
for monitoring the effect of human papillomavirus (HPV) vaccine on pre-invasive cervical …

… Genital warts in young Australians five years into national human papillomavirus vaccination
… New approaches to prophylactic human papillomavirus vaccines for cervical cancer …

… Human papillomavirus (HPV) vaccines are among the most effective vaccines available, the
first to prevent infection by a mucosatropic sexually transmitted infectious agent and to do so …

… vaccines, both prophylactic and therapeutic, with an emphasis on the selection of antigens
and adjuvants, as well as implications for vaccine … expansion among HPV vaccine recipients, …

… the protection achieved by these vaccines against HPV induced disease … Emerging evidence
shows that very low antibody … the RCTs and the emerging data on population effectiveness…